Definitions

Sorry, no definitions found. You may find more data at abbott's.

Etymologies

Sorry, no etymologies found.

Examples

  • Abbott's earnings excluding the costs exceeded analysts 'expectations, though the sales figure fell short -- a scenario similar to what unfolded in rival Johnson & Johnson 's earnings report Tuesday, when J & J cautioned that overall health-care spending growth was decelerating.

    Abbott Profit Falls 40% on Acquisition, Recall Costs

  • There are pictures by name photographers, such as Berenice Abbott's famous sliver of a cityscape, "Financial District, c. 1932," and Paul Woolf's smog shrouded "City Symphony, c. 1935," with water tanks arrayed across the foreground like notes on a staff of music.

    The Sky-Highs and Lows of City Scenes

  • In the case of Abbott's Meridia, the agency said the "very modest weight loss" from the drug didn't justify its cardiovascular risk.

    FDA Rejects Orexigen-Takeda Diet Drug

  • Sales of Abbott's nutritional products, which include Similac, declined 1.5% to $1.37 billion due to the product recall.

    Abbott Profit Falls 40% on Acquisition, Recall Costs

  • Hannah VerdierAfter a closely mimicking the plots of its UK antecedent for the first four or so episodes, Shameless comes up with a storyline that deviates somewhat from Paul Abbott's original, with Frank Gallagher swearing off alcohol for a fortnight in order to earn $3,000.

    TV highlights 11/08/2011: The Culture Show At The Edinburgh Festival | Torchwood: Miracle Day | The Killing | The Forgotten Blitz | Little Box Of Horrors | Shameless US

  • In addition, the layoffs affect some workers in Abbott's diagnostics and pharmaceutical manufacturing operations, Mr. Stoffel said.

    Abbott's Earnings Rise

  • For the fourth quarter, Abbott's profit rose to $1.6 billion, or $1.02 a share, from $1.4 billion, or 92 cents a share, a year earlier.

    Abbott's Earnings Rise

  • The company attributed some of the layoffs to the impending mid-2012 expiration of Abbott's contract to supply the artery-opening stent Promus to Boston Scientific Corp. Boston Scientific is shifting to a new version of Promus that it will manufacture internally.

    Abbott's Earnings Rise

  • Abbott's forecast implies an increase in earnings excluding certain items of about 7%, down from double-digit growth over the past five years.

    Abbott's Earnings Rise

  • A key product, he says, is Abbott's PathVysion test, which measures the HER-2 gene, a primary target for the breast cancer drug Herceptin, made by Roche.

    Companies Aim to Personalize Therapy

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.